ロード中...
Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome
Chemotherapy-induced peripheral neuropathy (CIPN) is common, frequently limits chemotherapy dosing, and negatively impacts quality of life. The National Cancer Institute Common Toxicity Criteria for Adverse Events (CTCAE), version 4.0, and the Total Neuropathy Score clinical version (TNSc) are both...
保存先:
| 出版年: | J Neurooncol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5955867/ https://ncbi.nlm.nih.gov/pubmed/28271282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-017-2389-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|